Progress Update
Lung cancer survivor Pamela Bowman (left) and radiation therapist Stephanie Bazille (right); proton therapy treatments

Lung cancer, like all cancers, has many forms. Each type differs in the specific molecular malfunctions that promote its progression. As the Lung Cancer Moon Shot aims to find drugs that target every aberration, using agents already approved for other cancers may speed the process. We’ve identified two leukemia drugs to test against lung cancer targets.

Learn more about the progress of the Lung Cancer Moon Shot.

About Lung Cancer

Focused on patients

Research at MD Anderson has daily impact on our patients. They come from all over the world, with every form of lung cancer. They benefit from the latest therapies, delivered by experts known for advancing their fields.

Learn more
Research Projects
Lung Cancer Moon Shot Leaders; (left to right): Stephen Swisher, M.D., Head, Division of Surgery; John Heymach, M.D., Ph.D., Chair, Thoracic/Head and Neck Medical Oncology

In our Lung Cancer Moon Shot, we’re profiling tumors to find cancer-driving mutations and choose the best therapies aimed at those alterations. We’re combining biomarkers and CT imaging to improve lung cancer screening. And we’re using new strategies to stop smoking — lung cancer’s top cause — and prevent kids from starting.

Learn more
MD Anderson and the Moon Shots Program
Making Cancer History®

New knowledge and progress-enabling technologies make this the time to reduce cancer deaths. MD Anderson's comprehensive Moon Shots Program capitalizes on these novel resources as it builds on a 70-plus-year history of renowned expertise, lifesaving innovation and global impact.

Learn more
Urgent Need

Lung cancer is the leading cause of cancer deaths — yet research dollars for lung cancer lag sorely behind money dedicated to cancers that claim far fewer lives. Help fund research with your gift.

Story of Hope

Reba Kennedy counts her blessings eight years after complicated surgery on a late-stage tumor others considered inoperable. Read Reba’s story.

Reba Kennedy, patient, survivor, lung cancer
Lung Cancer

More than 28,000 people who’ve never smoked die of lung cancer each year. If we consider only the 15% of lung cancers diagnosed in never-smokers as a separate disease, it would be the sixth-leading cause of U.S. cancer deaths.

Research Update

Finding new uses for existing therapies can shave years and millions of dollars from the cancer drug development process. MD Anderson lung researchers are collaborating with our Institute for Applied Cancer Science to channel drugs used in other malignancies against mutations shared in common with lung cancer.

Lung Cancer Moon Shot team; researcher in the lab